All Articles by Author:
Noshin Noorjahan
Newsletters
Modeling Mesenchymal Stromal Cell Support to Hematopoiesis within a Novel 3D Artificial Marrow Organoid System
[Scientific Reports] The authors reported an original, fully-human in vitro 3D model of the bone marrow microenvironment dedicated to study interactions taking place between mesenchymal stromal cells and hematopoietic stem and progenitor cells during the hematopoietic differentiation.
Newsletters
Patient-Derived Cortical Organoids Reveal Senescence of Neural Progenitor Cells in Hutchinson-Gilford Progeria Syndrome
[Aging Cell] Scientists established cortical organoids derived from Hutchinson-Gilford progeria syndrome (HGPS) patient-iPSCs from patients with HGPS to investigate the role of progerin in the brain.
Newsletters
Early-Life Exposure to Polypropylene Nanoplastics Induces Neurodevelopmental Toxicity in Mice and Human iPSC-Derived Cerebral Organoids
[Journal of Nanobiotechnology] The authors investigated the impact of maternal exposure to polypropylene nanoplastics on fetal brain development and neurobehavioral outcomes in a mouse model and further explored its mechanism in human cerebral organoids.
Newsletters
Megan Orzalli Awarded Competitive Biomedical Science Research Grant
[UMass Chan Medical School] Megan Orzalli is one of eight recipients of the 2025 Investigators in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund.
Neural Cell News
Restoration of Striatal Neuroprotective Pathways by Kinase Inhibitor Treatment of Parkinson’S Disease-Linked LRRK2-Mutant Mice
[Science Signaling] Researchers tested the leucine-rich repeat kinase 2 (LRRK2) inhibitor MLi-2 in a mouse model of early stage, LRRK2 mutation–associated Parkinson's disease.
Neural Cell News
Glial Reactivity Correlates with Synaptic Dysfunction across Aging and Alzheimer’s Disease
[Nature Communications] Scientists investigated the association between glial reactivity and synaptic dysfunction biomarkers in cerebrospinal fluid from 478 individuals in cognitively unimpaired and cognitively impaired individuals.
Popular
Upstream Bio Announces First Patient Dosed in Phase II Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)
Upstream Bio, Inc. announced that the first patient has been dosed in the company’s Phase II clinical trial evaluating verekitug in patients with COPD, broadening the global development program...
Nuclear Localization and Upregulation of BAI1 in Alveolar Macrophages during LPS-Induced Acute Lung Injury
Investigators investigated brain-specific angiogenesis inhibitor-1 (BAI1) expression in alveolar macrophages and changes in BAI1 expression levels in an acute lung injury (ALI) model. A mouse model of ALI was...
FibroBiologics Confirms Ability to Manufacture CybroCellâ„¢ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank
[FibroBiologics, Inc. (Globe Newswire)] FibroBiologics, Inc. announced an advancement in its cartilage repair program. CYWC628 spheroids used in its wound healing program can be directly differentiated into chondrocytes.